ponalrestat

ponalrestat

See Aldose reductase inhibitor.
References in periodicals archive ?
In past decades, the once most promising ARIs such as sorbinil, tolrestat, zopolrestat, and ponalrestat were withdrawn from clinical trials because of unsatisfactory efficacy and severe side effects [4, 7].
Clinical trials were initiated for sorbinil, ponalrestat, alrestatin, zopolrestat and tolrestat.